{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:42:54Z","timestamp":1777912974013,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s12020-018-1801-3","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T17:30:02Z","timestamp":1542216602000},"page":"470-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Larger ascending aorta in primary aldosteronism: a 3-year prospective evaluation of adrenalectomy vs. medical treatment"],"prefix":"10.1007","volume":"63","author":[{"given":"Guido","family":"Zavatta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Di Dalmazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Bracchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mosconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Balacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uberto","family":"Pagotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Vicennati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"issue":"1","key":"1801_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40292-014-0039-2","volume":"21","author":"GP Rossi","year":"2014","unstructured":"G.P. Rossi, A. Dalla C\u00e0, Clinical management of primary aldosteronism. High Blood Press Cardiovasc Prev. 21(1), 71\u201375 (2014). \n                    https:\/\/doi.org\/10.1007\/s40292-014-0039-2","journal-title":"High Blood Press Cardiovasc Prev."},{"issue":"6","key":"1801_CR2","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1210\/en.2003-0279","volume":"144","author":"WF Young","year":"2003","unstructured":"W.F. Young, Minireview: primary aldosteronism\u2014changing concepts in diagnosis and treatment. Endocrinology 144(6), 2208\u20132213 (2003). \n                    https:\/\/doi.org\/10.1210\/en.2003-0279","journal-title":"Endocrinology"},{"key":"1801_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"C. Catena, G. Colussi, E. Nadalini, A. Chiuch, S. Baroselli, R. Lapenna, L.A. Sechi, Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch. Intern. Med. 168, 80\u201385 (2008)","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"1801_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","volume":"62","author":"S Savard","year":"2013","unstructured":"S. Savard, L. Amar, P.-F. Plouin, O. Steichen, Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 62(2), 331\u2013336 (2013 Aug)","journal-title":"Hypertension"},{"issue":"3","key":"1801_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","volume":"19","author":"GP Rossi","year":"2008","unstructured":"G.-P. Rossi, L.A. Sechi, G. Giacchetti, V. Ronconi, P. Strazzullo, J.W. Funder, Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol. Metab. 19(3), 88\u201390 (2008 Apr)","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"1801_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"S. Monticone, F. D\u2019Ascenzo, C. Moretti et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6(1), 41\u201350 (2018). \n                    https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"1801_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"GP Rossi","year":"2006","unstructured":"G.P. Rossi, G. Bernini, G. Desideri, B. Fabris, C. Ferri, G. Giacchetti, C. Letizia, M. Maccario, M. Mannelli, M. Matterello, D. Montemurro, G. Palumbo, D. Rizzoni, E. Rossi, A.C. Pessina, F. Mantero, Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48(2), 232\u2013238 (2006)","journal-title":"Hypertension"},{"key":"1801_CR8","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"L.A. Sechi, M. Novello, R. Lapenna, S. Baroselli, E. Nadalini, G.L. Colussi, C. Catena, Long-term renal outcomes in patients with primary aldosteronism. J Am Med Assoc 295, 2638\u20132645 (2006)","journal-title":"J Am Med Assoc"},{"issue":"3","key":"1801_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","volume":"60","author":"M Reincke","year":"2012","unstructured":"M. Reincke, E. Fischer, S. Gerum, K. Merkle, S. Schulz, A. Pallauf, M. Quinkler, G. Hanslik, K. Lang, S. Hahner, B. Allolio, C. Meisinger, R. Holle, F. Beuschlein, M. Bidlingmaier, S. Endres, Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry. Hypertension 60(3), 618\u2013624 (2012)","journal-title":"Hypertension"},{"key":"1801_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1291\/hypres.20.85","volume":"20","author":"A Tanabe","year":"1997","unstructured":"A. Tanabe, M. Naruse, K. Naruse, M. Hase, T. Yoshimoto, M. Tanaka, T. Seki, R. Demura, H. Demura, Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. Hypertens. Res. 20, 85\u201390 (1997)","journal-title":"Hypertens. Res."},{"key":"1801_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.recesp.2012.07.025","volume":"66","author":"M Abad-Cardiel","year":"2013","unstructured":"M. Abad-Cardiel, B. Alvarez-\u00c1lvarez, L. Luque-Fernandez, C. Fern\u00e1ndez, A. Fern\u00e1ndez-Cruz, N. Martell-Claros, Hypertension caused by primary hyperaldosteronism: increased heart damage and cardiovascular risk. Rev. Esp. Cardiol. 66, 47\u201352 (2013)","journal-title":"Rev. Esp. Cardiol."},{"issue":"10","key":"1801_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med. 341(10), 709\u2013717 (1999)","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"1801_CR13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, B. Roniker, R. Bittman, S. Hurley, J. Kleiman, M. Gatlin, Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348(14), 1309\u20131321 (2003)","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"1801_CR14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1139\/y05-068","volume":"83","author":"MF Neves","year":"2005","unstructured":"M.F. Neves, F. Amiri, A. Virdis, Q.N. Diep, E.L. Schiffrin, Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy. Can. J. Physiol. Pharmacol. 83(11), 999\u20131006 (2005)","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"1801_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1042\/CS20070123","volume":"113","author":"AM Marney","year":"2007","unstructured":"A.M. Marney, N.J. Brown, Aldosterone and end-organ damage. Clin. Sci. (Lond.) 113, 267\u2013278 (2007)","journal-title":"Clin. Sci. (Lond.)"},{"key":"1801_CR16","doi-asserted-by":"publisher","unstructured":"J. Widimsky Jr., B. Strauch, O. Petr\u00e1k, J. Rosa, Z. Somloova, T. Zelinka, R. Holaj. Vascular disturbances in primary aldosteronism: clinical evidence. Kidney Blood Press. Res. 529\u2013533 (2012). \n                    https:\/\/doi.org\/10.1159\/000340031","DOI":"10.1159\/000340031"},{"issue":"7","key":"1801_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039235","volume":"7","author":"N L\u00f3pez Andr\u00e9s","year":"2012","unstructured":"N. L\u00f3pez Andr\u00e9s, A. Tesse, V. Regnault, H. Louis, V. Cattan, S.N. Thornton, C. Labat, A. Kakou, S. Tual-Chalot, S. Faure, P. Challande, M. Osborne-Pellegrin, M.C. Martinez, P. Lacolley, R. Andriantsitohaina, Increased microparticle production and impaired microvascular endothelial function in aldosterone-salt-treated rats: protective effects of polyphenols. PLoS One 7(7), e39235 (2012)","journal-title":"PLoS One"},{"key":"1801_CR18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11596-010-0362-3","volume":"30","author":"Y Yan","year":"2010","unstructured":"Y. Yan, J. Ouyang, C. Wang, Z. Wu, X. Ma, H. Li, H. Xu, Z. Hu, J. Li, B. Wang, T. Shi, D. Gong, D. Ni, X. Zhang, Aortic cell apoptosis in rat primary aldosteronism model.J. Huazhong Univ. Sci. Technol. [Med. Sci.] 30, 385\u2013390 (2010). \n                    https:\/\/doi.org\/10.1007\/s11596-010-0362-3","journal-title":"J. Huazhong Univ. Sci. Technol. [Med. Sci.]"},{"issue":"7","key":"1801_CR19","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/ATVBAHA.112.300820","volume":"33","author":"S Liu","year":"2013","unstructured":"S. Liu, Z. Xie, A. Daugherty, L.A. Cassis, K.J. Pearson, M.C. Gong, Z. Guo, Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high salt. Arterioscler. Thromb. Vasc. Biol. 33(7), 1568\u20131579 (2013)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"1801_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000095787","volume":"108","author":"SH Ahmed","year":"2007","unstructured":"S.H. Ahmed, N.M. Husain, S.N. Khawaja, C.V. Massey, F.S. Pettyjohn, Is primary hyperaldosteronism a risk factor for aortic dissection? Cardiology 108(1), 48\u201350 (2007)","journal-title":"Cardiology"},{"issue":"2","key":"1801_CR21","first-page":"156","volume":"69","author":"M Podg\u00f3rski","year":"2011","unstructured":"M. Podg\u00f3rski, A. Derkacz, R. Por\u0119ba, K. Belowska-Bie\u0144, K. Gruber, A. Szuba, R. Andrzejak, Aortic dissection\u2014a rare complication of primary aldosteronism\u2014a case report. Kardiol. Pol. 69(2), 156\u2013158 (2011). discussion 159","journal-title":"Kardiol. Pol."},{"issue":"3","key":"1801_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF02738886","volume":"10","author":"KY Lam","year":"1999","unstructured":"K.-Y. Lam, C.-Y. Lo, The clinicopathologic significance of unilateral adrenal cortical hyperplasia: report of an unusual case and a review of the literature. Endocr. Pathol. 10(3), 243\u2013249 (1999)","journal-title":"Endocr. Pathol."},{"key":"1801_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.5551\/jat.4010","volume":"17","author":"Y Ito","year":"2010","unstructured":"Y. Ito, K. Yoshimura, Y. Matsuzawa, J. Saito, H. Ito, H. Furukawa, K. Okura, M. Fukata, T. Konishi, T. Nishikawa, Successful treatment of a mycotic aortic pseudoaneurysm in a patient with type 2 diabetes mellitus while treating primary aldosteronism with spironolactone. J. Atheroscler. Thromb. 17, 771\u2013775 (2010). [cited 13 November 2014]","journal-title":"J. Atheroscler. Thromb."},{"key":"1801_CR24","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 18, 1440\u20131463 (2005)","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"8","key":"1801_CR25","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/ejechocard\/jeq056","volume":"11","author":"A Evangelista","year":"2010","unstructured":"A. Evangelista, Fa Flachskampf, R. Erbel, F. Antonini-Canterin, C. Vlachopoulos, G. Rocchi, R. Sicari, P. Nihoyannopoulos, J. Zamorano, Echocardiography in aortic diseases: EAE recommendations for clinical practice. Eur. J. Echocardiogr. 11(8), 645\u2013658 (2010)","journal-title":"Eur. J. Echocardiogr."},{"issue":"3","key":"1801_CR26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/01.CIR.91.3.734","volume":"91","author":"RS Vasan","year":"1995","unstructured":"R.S. Vasan, M.G. Larson, D. Levy, Determinants of echocardiographic aortic root size. The Framingham Heart Study. Circulation 91(3), 734\u2013740 (1995)","journal-title":"Circulation"},{"issue":"6","key":"1801_CR27","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0894-7317(05)80003-3","volume":"8","author":"RS Vasan","year":"1995","unstructured":"R.S. Vasan, M.G. Larson, E.J. Benjamin, D. Levy, The echocardiographic reference values for aortic root size: the Framingham Heart Study. J. Am. Soc. Echocardiogr. 8(6), 793\u2013800 (1995). Boston, Massachusetts, and Bethesda M","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"5","key":"1801_CR28","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1161\/01.HYP.37.5.1229","volume":"37","author":"V Palmieri","year":"2001","unstructured":"V. Palmieri, J.N. Bella, D.K. Arnett, M.J. Roman, A. Oberman, D.W. Kitzman, P.N. Hopkins, M. Paranicas, D.C. Rao, R.B. Devereux, Aortic root dilatation at sinuses of valsalva and aortic regurgitation in hypertensive and normotensive subjects: the Hypertension Genetic Epidemiology Network Study. Hypertension 37(5), 1229\u20131235 (2001)","journal-title":"Hypertension"},{"key":"1801_CR29","doi-asserted-by":"publisher","unstructured":"Erbel R., Eggebrecht H. Aortic dimensions and the risk of dissection. Heart. (2006) \n                    https:\/\/doi.org\/10.1136\/hrt.2004.055111\n                    \n                  .","DOI":"10.1136\/hrt.2004.055111"},{"issue":"9","key":"1801_CR30","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"J.W. Funder, R.M. Carey, C. Fardella, C.E. Gomez-Sanchez, F. Mantero, M. Stowasser, J.W.F. Young, V.M. Montori, Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 93(9), 3266\u20133281 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"1801_CR31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1530\/EJE-11-1039","volume":"166","author":"G Dalmazi Di","year":"2012","unstructured":"G. Di Dalmazi, V. Vicennati, E. Rinaldi, A.M. Morselli-Labate, E. Giampalma, C. Mosconi, U. Pagotto, R. Pasquali, Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. Eur. J. Endocrinol. 166(4), 669\u2013677 (2012)","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"1801_CR32","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"L.K. Nieman, B.M.K. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. Endocr. Soc. 93(5), 1526\u20131540 (2008)","journal-title":"J. Clin. Endocrinol. Metab. Endocr. Soc."},{"issue":"7","key":"1801_CR33","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","volume":"25","author":"R Holaj","year":"2007","unstructured":"R. Holaj, T. Zelinka, D. Wichterle, O. Petr\u00e1k, B. Strauch, J. Widimsk\u00fd, Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension. J. Hypertens. 25(7), 1451\u20131457 (2007)","journal-title":"J. Hypertens."},{"issue":"3\u20135","key":"1801_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jsbmb.2008.03.005","volume":"109","author":"V Cachofeiro","year":"2008","unstructured":"V. Cachofeiro, M. Miana, N. de Las Heras, B. Mart\u00edn-Fern\u00e1ndez, S. Ballesteros, J. Fern\u00e1ndez-Tresguerres, V. Lahera, Aldosterone and the vascular system. J. Steroid Biochem. Mol. Biol. 109(3\u20135), 331\u2013335 (2008). [cited 28 April 2014]","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"28","key":"1801_CR35","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"G. Mancia, R. Fagard, K. Narkiewicz, J. Redon, A. Zanchetti, M. B\u00f6hm, T. Christiaens, R. Cifkova, G. De Backer, A. Dominiczak, M.E. Galderisi, D. Grobbee, T. Jaarsma, P.E. Kirchhof, S. Kjeldsen, S.J. Laurent, A.M. Manolis, P. Nilsson, L.M. Ruilope, R. E. Schmieder, P.A. Sirnes, P. Sleight, M. Viigima, B. Waeber, F. Zannad, 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 34(28), 2159\u20132219 (2013)","journal-title":"Eur. Heart J."},{"key":"1801_CR36","first-page":"e266","volume":"121","author":"S Buckvold","year":"2010","unstructured":"S. Buckvold, A.T. Yetman, L.F. Hiratzka, G.L. Bakris, J.A. Beckman, R.M. Bersin et al.. 2010 ACCF\/AHA\/AATS\/ACR\/ASA\/SCA\/SCAI\/SIR\/STS\/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, A. Circulation 121, e266\u2013e369 (2010)","journal-title":"Circulation"},{"issue":"5","key":"1801_CR37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11748-009-0417-1","volume":"58","author":"H Hirai","year":"2010","unstructured":"H. Hirai, T. Shibata, Y. Sasaki, H. Fujii, S. Kubo, S. Suehiro, Simultaneous surgery for chronic aortic dissection and adrenal adenoma with primary aldosteronism. Gen. Thorac. Cardiovasc. Surg. 58(5), 235\u2013237 (2010). discussion 238","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"1801_CR38","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/000331979905000609","volume":"50","author":"M Arshad","year":"1999","unstructured":"M. Arshad, A.M. Safi, T. Kwan, E. Afflu, M. Alam, J.E. Anderson, L. T. Clark, Coronary artery aneurysms, aortic dissection, and hypertension secondary to primary aldosteronism: a rare triad. A case report. Angiology 50(6), 503\u2013508 (1999)","journal-title":"Angiology"},{"issue":"4","key":"1801_CR39","first-page":"185","volume":"28","author":"JM Tarti\u00e8re","year":"2003","unstructured":"J.-M. Tarti\u00e8re, L. Kesri, J.-J. Mourad, M. Safar, J. Blacher, Primary aldosteronism. A risk factor for aortic dissection? J. Mal. Vasc. 28(4), 185\u2013189 (2003)","journal-title":"J. Mal. Vasc."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1801-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-018-1801-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-018-1801-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:44:16Z","timestamp":1573692256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-018-1801-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1801"],"URL":"https:\/\/doi.org\/10.1007\/s12020-018-1801-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]},"assertion":[{"value":"20 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}